ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Remdesivir, tocilizumab being considered for ‘restricted use’ on severely ill COVID-19 patients
June 12, 2020Reportedly, some more drugs to be used in combination with hydroxychloroquine may be added to the protocol. -
China approves use of Roche arthritis drug for some Covid-19 patients
March 05, 2020Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients who show serious lung damage. -
Final NHS nod for Roche’s RoActemra
July 16, 2018Roche/Chugai’s RoActemra should be routinely offered throughout the NHS to adults with giant cell arteritis (GCA) within the next three months, following a final green light from cost regulators. -
Tocilizumab Beats Steroids for Controlling Blood Vessel Inflammation in Study
July 27, 2017The drug tocilizumab performs better than steroids in treating the most common form of blood vessel inflammation known as giant cell arteritis, a new study has shown.
Pharma Sources Insight January 2025
